Researchers Utilize Smartphones to Monitor Cancer Treatment

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Contact

Abby Robinson
Research News and Publications
abby@innovate.gatech.edu
404-385-3364

Sidebar Content
No sidebar content submitted.
Summaries

Summary Sentence:

Researchers are developing software to measure platelet count, neutrophil count and hemoglobin levels in real time at home.

Full Summary:

Researchers are developing software to measure platelet count, neutrophil count and hemoglobin levels in real time at home. The information is vital for assessing the degree of toxicity from treatment with chemotherapy or radiation.

For individuals receiving treatment for cancer, complete blood counts are vital for assessing the degree of toxicity from treatment with chemotherapy or radiation, which places patients at high risk for serious infections and requires that they remain at home to prevent acquiring infections from public places.

Instead of making weekly visits to clinics or commercial laboratories to have blood drawn, patients may one day use a cell phone attachment and software being developed by biomedical engineers to measure platelet count, neutrophil count and hemoglobin levels in real time at home. The information can be obtained from a single drop of blood obtained via finger prick.

Analogous to at-home glucose monitors that diabetics use, the device – called the Quantum CBC – uses a cell phone-integrated microscope to analyze the blood, which is loaded into a disposable cartridge. The cartridge contains a channel with a fluorescent dye that binds to platelets and white blood cells, along with quantum dots targeted to neutrophils.

“Using this system, patients could test themselves whenever and wherever they desire to determine when they are at risk for infection, when they can leave their homes and when they require a transfusion,” said Wilbur Lam, an assistant professor with a joint appointment in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University and the Department of Pediatrics at Emory University. “This device will empower cancer patients, allowing them to take an active role in their treatment and enhance their quality of life.”

Lam is collaborating on this project with Gang Bao, the Robert A. Milton Chair in Biomedical Engineering and College of Engineering Distinguished Professor at Georgia Tech. The project is supported by the Coulter Foundation. 

Research News & Publications Office
Georgia Institute of Technology
75 Fifth Street, N.W., Suite 314
Atlanta, Georgia 30308 USA

Media Relations Contacts: Abby Robinson (abby@innovate.gatech.edu; 404-385-3364) or John Toon (jtoon@gatech.edu; 404-894-6986)

Writer: Abby Robinson

Additional Information

Groups

Research Horizons

Categories
Cancer Research, Engineering, Research
Related Core Research Areas
No core research areas were selected.
Newsroom Topics
No newsroom topics were selected.
Keywords
blood, cancer, chemotherapy, college of engineering, Department of Biomedical Engineering, Gang Bao, mobile app, Quantum CBC, radiation, smartphone, Treatment, Wilbur Lam
Status
  • Created By: Abby Vogel Robinson
  • Workflow Status: Published
  • Created On: May 30, 2012 - 4:46pm
  • Last Updated: Oct 7, 2016 - 11:12pm